Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MULTIFUNCTIONAL FUSION PROTEIN DRUG TARGETING AND KILLING PATHOGENS AND/OR TUMOR CELLS
Document Type and Number:
WIPO Patent Application WO/2023/011575
Kind Code:
A1
Abstract:
Provided are a fusion protein containing a recognition function domain, a recruitment function domain, an activation function domain, and an auxiliary killing function domain, a construction method therefor and an application thereof in the field of biomedicines. The fusion protein can recognize pathogens and mobilize an immune system to kill the pathogens, and has important application value for new drug research and development for treating pathogen infection or tumor cells.

Inventors:
LIN XIN (CN)
YUAN JIANLONG (CN)
Application Number:
PCT/CN2022/110178
Publication Date:
February 09, 2023
Filing Date:
August 04, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV TSINGHUA (CN)
International Classes:
C07K19/00; A61P31/00; A61P35/00; C07K16/08; C07K16/30
Domestic Patent References:
WO2020068261A12020-04-02
WO2019129053A12019-07-04
Foreign References:
CN1382158A2002-11-27
CN104159600A2014-11-19
Other References:
CLAUDIA HEUSER; STEFAN GUHLKE; ALEXANDER MATTHIES; HANS BENDER; STEFAN BARTH; VOLKER DIEHL; HINRICH ABKEN; ANDREAS HOMBACH: "Anti‐CD30‐scFv‐Fc‐IL‐2 antibody‐cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC., US, vol. 110, no. 3, 27 February 2004 (2004-02-27), US , pages 386 - 394, XP071282167, ISSN: 0020-7136, DOI: 10.1002/ijc.20098
HAO SHILEI, JIN DAVID, ZHANG SHUGUANG, QING RUI: "QTY Code-designed Water-soluble Fc-fusion Cytokine Receptors Bind to their Respective Ligands", QRB DISCOVERY, vol. 1, 1 January 2020 (2020-01-01), XP055924607, DOI: 10.1017/qrd.2020.4
GAO RUI, WANG MIN; ZHANG JUAN: "Prospect of Antibody-Cytokine Fusion Proteins for the Therapy of Cancer", PHARMACEUTICAL BIOTECHNOLOGY, vol. 27, no. 2, 1 January 2020 (2020-01-01), pages 182 - 188, XP093032875, ISSN: 1005-8915, DOI: 10.19526/j.cnki.1005-8915.20200219
Attorney, Agent or Firm:
BEIJING IPLING INTELLECTUAL PROPERTY LAW FIRM (CN)
Download PDF: